• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.

作者信息

Smith M D, Wuthiekanun V, Walsh A L, White N J

机构信息

Mahidol University, Bangkok, Thailand.

出版信息

J Antimicrob Chemother. 1996 Mar;37(3):611-5. doi: 10.1093/jac/37.3.611.

DOI:10.1093/jac/37.3.611
PMID:9182118
Abstract

Four carbapenem antibiotics were tested for their in-vitro activities (MICs, MBCs and time-kill studies) against Burkholderia pseudomallei. The carbapenems were all more active than either ceftazidime or co-amoxiclav against strains of B. pseudomallei with a normal susceptibility pattern. Biapenem was the most active antibiotic tested. All four carbapenems retained bactericidal activity against 24 strains of B. pseudomallei with reduced susceptibility to ceftazidime and/or co-amoxiclav.

摘要

相似文献

1
In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.
J Antimicrob Chemother. 1996 Mar;37(3):611-5. doi: 10.1093/jac/37.3.611.
2
Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.65株类鼻疽伯克霍尔德菌和鼻疽伯克霍尔德菌对35种抗菌药物的药敏试验
J Antimicrob Chemother. 2004 Dec;54(6):1134-8. doi: 10.1093/jac/dkh471. Epub 2004 Oct 27.
3
Optical microscopy reveals the dynamic nature of B. pseudomallei morphology during β-lactam antimicrobial susceptibility testing.光学显微镜揭示了在β-内酰胺类抗菌药物药敏试验过程中,假鼻疽伯克霍尔德菌形态的动态变化。
BMC Microbiol. 2020 Jul 16;20(1):209. doi: 10.1186/s12866-020-01865-w.
4
Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.从沙潘西提普拉宋医院患者中分离出的类鼻疽伯克霍尔德菌中bla(PenA)和bla(OXA)的流行情况及其对头孢他啶和碳青霉烯类药物的敏感性。
J Med Assoc Thai. 2016 Jan;99 Suppl 1:S12-6.
5
Burkholderia ubonensis Meropenem Resistance: Insights into Distinct Properties of Class A β-Lactamases in Burkholderia cepacia Complex and Burkholderia pseudomallei Complex Bacteria.乌本伯克霍尔德菌对美罗培南的耐药性:洋葱伯克霍尔德菌复合体和类鼻疽伯克霍尔德菌复合体细菌中 A 类β-内酰胺酶特性的研究进展。
mBio. 2020 Apr 14;11(2):e00592-20. doi: 10.1128/mBio.00592-20.
6
In vitro activity of tebipenem against Burkholderia pseudomallei.替比培南对类鼻疽伯克霍尔德菌的体外活性
Int J Antimicrob Agents. 2013 Oct;42(4):375. doi: 10.1016/j.ijantimicag.2013.06.016. Epub 2013 Aug 24.
7
In vitro activity of doripenem against Burkholderia pseudomallei.多黏菌素B对类鼻疽伯克霍尔德菌的体外活性。
Antimicrob Agents Chemother. 2009 Jul;53(7):3115-7. doi: 10.1128/AAC.00893-08. Epub 2009 Apr 13.
8
Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-Lactamase.揭示β-内酰胺酶的“扭曲”:伯克霍尔德菌假鼻疽杆菌PenIβ-内酰胺酶C69F变体中高水平头孢他啶耐药性的机制基础。
Antimicrob Agents Chemother. 2015 Nov 23;60(2):777-88. doi: 10.1128/AAC.02073-15. Print 2016 Feb.
9
Antibiotic Resistance Markers in Burkholderia pseudomallei Strain Bp1651 Identified by Genome Sequence Analysis.通过基因组序列分析鉴定的伯克霍尔德菌假鼻疽亚种Bp1651中的抗生素抗性标记
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00010-17. Print 2017 Jun.
10
Susceptibility of Pseudomonas pseudomallei to some newer beta-lactam antibiotics and antibiotic combinations using time-kill studies.
J Antimicrob Chemother. 1994 Jan;33(1):145-9. doi: 10.1093/jac/33.1.145.

引用本文的文献

1
Meropenem-resistant Burkholderia pseudomallei: a concerning single case in Australia with no prior meropenem exposure.耐美罗培南的类鼻疽伯克霍尔德菌:澳大利亚一例令人担忧的病例,此前未接触过美罗培南。
Access Microbiol. 2024 Oct 28;6(10). doi: 10.1099/acmi.0.000619.v4. eCollection 2024.
2
Effective Therapeutic Options for Melioidosis: Antibiotics versus Phage Therapy.类鼻疽的有效治疗选择:抗生素与噬菌体疗法
Pathogens. 2022 Dec 21;12(1):11. doi: 10.3390/pathogens12010011.
3
Andrographolide stabilized-silver nanoparticles overcome ceftazidime-resistant Burkholderia pseudomallei: study of antimicrobial activity and mode of action.
穿心莲内酯稳定化银纳米颗粒克服头孢他啶耐药伯克霍尔德氏菌:抗菌活性和作用模式研究。
Sci Rep. 2022 Jun 23;12(1):10701. doi: 10.1038/s41598-022-14550-x.
4
Silver Nanoparticles Enhance Antimicrobial Efficacy of Antibiotics and Restore That Efficacy against the Melioidosis Pathogen.银纳米颗粒增强抗生素的抗菌功效,并恢复对类鼻疽病原体的抗菌效力。
Antibiotics (Basel). 2021 Jul 10;10(7):839. doi: 10.3390/antibiotics10070839.
5
Unusual presentation of melioidosis in a returning traveler.一名归国旅行者中类鼻疽的不寻常表现。
IDCases. 2020 May 12;20:e00809. doi: 10.1016/j.idcr.2020.e00809. eCollection 2020.
6
Human Melioidosis.类鼻疽病。
Clin Microbiol Rev. 2020 Mar 11;33(2). doi: 10.1128/CMR.00006-19. Print 2020 Mar 18.
7
Melioidosis.类鼻疽病。
Nat Rev Dis Primers. 2018 Feb 1;4:17107. doi: 10.1038/nrdp.2017.107.
8
Treatment and prophylaxis of melioidosis.类鼻疽的治疗与预防。
Int J Antimicrob Agents. 2014 Apr;43(4):310-8. doi: 10.1016/j.ijantimicag.2014.01.005. Epub 2014 Feb 3.
9
Septicemic melioidosis: a case report and literature review.败血性类鼻疽病:一例病例报告及文献复习。
J Thorac Dis. 2014 Feb;6(2):E1-4. doi: 10.3978/j.issn.2072-1439.2014.01.20.
10
Melioidosis of chest wall masquerading as a tubercular cold abscess.伪装成结核性寒性脓肿的胸壁类鼻疽病
J Surg Tech Case Rep. 2012 Jul;4(2):115-7. doi: 10.4103/2006-8808.110254.